The Compounding Chemotherapy Market is developing as healthcare providers increasingly seek customized treatment options for cancer patients. Compounded chemotherapy can be prepared to accommodate individual requirements, including specific dosage needs and formulation preferences that may not always be available through standard commercial products.

The market is being supported by the growing demand for personalized medicine and the increasing need for specialized oncology treatments. According to WiseGuyReports, the market was valued at USD 9.48 billion in 2024 and is projected to reach USD 16.5 billion by 2032. The report also indicates a CAGR of 7.18% during the forecast period.

Technology is playing an important role in the development of compounding practices. Automation, improved mixing technologies, quality-control systems, and other advancements can help pharmacies improve consistency and efficiency during preparation.

Hospitals, outpatient care centers, home healthcare providers, and pharmacy-compounding facilities represent important areas of use. Injectable, infusion, and oral compounds are among the major product categories covered in the market.

At the same time, strict quality requirements and regulatory compliance remain important considerations. As oncology care becomes increasingly personalized, demand for specialized compounding services is expected to remain an important factor shaping the market.